GlobeNewswire
-
Creative Medical Technology Holdings Highlights 93% Patient Response Rate and 65% Reduction in Average Pain Scores in Ultrasome™ Knee Osteoarthritis Study
20/10/2026 -
Inseer Appoints Eugene “Woody” Ritchey CEO to Lead Next Phase of Enterprise Growth
20/10/2026 -
Femasys Partners with SandsRx Pharmacy to Support FemaSeed® Fertility Portfolio Launch to OB/GYNs
20/10/2026 -
Centivo Adds Two Industry Veterans to Leadership Team
20/10/2026 -
Aeroflow Health Survey Finds Nearly Half of Medicaid Members Are Unprepared for 2027 Work Requirements
20/10/2026 -
Applied Biologics Announces Acceptance for Publication of Interim Results from Randomized Controlled CAMPX Trial Evaluating XWRAP®
20/10/2026 -
Omada Health to Present Peer-Reviewed Research on Improving Weight Loss and Body Composition During GLP-1 Treatment at World Obesity and Weight Management Congress
20/10/2026 -
Optum and Syneos Health Partner to Advance an Adaptive Clinical Development Model
20/10/2026 -
Solid Biosciences to Present Research Across Gene Therapy Development, Delivery and Manufacturing at ESGCT 2026
20/10/2026 -
BioVie Presents Data on Bezisterim in Parkinson’s Disease at the 2026 American Neurological Association Annual Meeting
20/10/2026 -
Biomolecular Holdings Announces Issuance of Foundational Patent for Revolutionary Dimeric Fusion Protein Technology
20/10/2026 -
Alignment Health Plan Recognized Among U.S. News & World Report’s 2027 Best Insurance Companies for Medicare Advantage
20/10/2026 -
Oncotelic Keynote to Highlight Partition and Aggregation as a Fundamental Principle for AI Enabled Discovery
20/10/2026 -
Madrigal Pharmaceuticals to Release Third-Quarter 2026 Financial Results and Host Webcast on November 3, 2026
20/10/2026 -
CPTx to present new in vivo data for its in vivo CAR T cell therapies at ESGCT 2026
20/10/2026 -
UEG Week: Teva and Sanofi’s Duvakitug Maintained Long-Term Positive Outcomes in New Phase 2b Data for Ulcerative Colitis and Crohn’s Disease
20/10/2026 -
Philips highlights Integrated Diagnostics’ role in the future of cardiovascular informatics following MediReport acquisition
20/10/2026 -
Stereotaxis to Report Third Quarter 2026 Financial Results on November 10, 2026
20/10/2026 -
Medicovestor Announces FDA Fast Track Designation for MC001, Its First-in-Class Chemoimmunotherapy ADC for Pancreatic Cancer
20/10/2026
Pages